Minimal Residual Disease in Acute Lymphoblastic Leukemia
1 vistas
administrator
06/15/23
The panelists, Raoul Tibes, MD, PhD; Stefan Faderl, MD; and Bijal D. Shah, MD, outline methods of measuring minimal residual disease and its role in the management of acute lymphoblastic leukemia.
Mostrar más
Comentarios de Facebook
No se encontraron comentarios